Skip to main content
Download PDF

Invasive candidiasis in the ICU: Prophylaxis versus preemptive treatment

Current Infectious Disease Reports volume 10, Article number: 454 (2008) Cite this article

Abstract

Candidemia/invasive candidiasis has increased in incidence over the past 15 years. Because of numerous risk factors, intensive care unit patients have a predilection for this type of infection. Most of these infections are acquired endogenously, but occasionally may result from an exogenous source. Antifungal prophylaxis and preemptive antifungal therapy have been developed to prevent candidemia/invasive candidiasis. Antifungal prophylaxis with azoles has been demonstrated to reduce candidemia, overall mortality, and attributable mortality. This strategy is also effective for the prevention of invasive fungal infection in liver transplant recipients. Preemptive treatment appears to be a more focused intervention that uses markers (eg, the presence of colonization) and serologic testing to trigger the initiation of antifungal therapy. Further developments in serologic testing are necessary to enhance the precision of selecting the patients at risk for candidemia/invasive candidiasis. The optimum agent to be used prophylactically and for preemptive therapy requires further clinical investigation.

References and Recommended Reading

  1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546–1554.

    PubMed  Article  Google Scholar 

  2. Wisplinghoff H, Bischoff T, Tallent SM, et al.: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309–317.

    PubMed  Article  Google Scholar 

  3. Azoulay E, Timsit J-F, Tafflet M, et al.: Candida colonization of the respiratory tree and subsequent Pseudomonas ventilator-associated pneumonia. Chest 2006, 129:110–117.

    PubMed  Article  Google Scholar 

  4. Clark TA, Slavinski SA, Morgan J, et al.: Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 2004, 42:4468–4472.

    PubMed  Article  CAS  Google Scholar 

  5. Sanchez V, Vazquez JA, Barth-Jones D, et al.: Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993, 94:577–582.

    PubMed  Article  CAS  Google Scholar 

  6. Vazquez JA, Sanchez V, Dmuchowski C, et al.: Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993, 168:195–201.

    PubMed  CAS  Google Scholar 

  7. Doi M, Homma M, Inaguchi S, et al.: Strain relatedness of Candida albicans strains isolated from children with leukemia and their bedside parents. J Clin Microbiol 1994, 32:2253–2259.

    PubMed  CAS  Google Scholar 

  8. Tortorano AM, Peman J, Bernhardt H, et al.: Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 23:317–322.

    PubMed  Article  CAS  Google Scholar 

  9. Hadley S, Lee WW, Ruthazer R, Nasraway SA Jr: Candidemia as a cause of septic shock and multiple organ failure in non-immunocompromised patients. Crit Care Med 2002, 30:1808–1814.

    PubMed  Article  Google Scholar 

  10. Beck-Sagué C, Jarvis WR: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993, 167:1247–1251.

    PubMed  Google Scholar 

  11. Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospital-acquired candidemia. A matched case-control study. Archiv Intern Med 1989, 149:2349–2353.

    Article  CAS  Google Scholar 

  12. Komshian SV, Uwaydah AK, Sobel JD, Crane LR: Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and valuation of factors influencing outcome. Rev Infect Dis 1989, 11:379–390.

    PubMed  CAS  Google Scholar 

  13. Winston DJ, Emmanouilides C, Busuttil RW: Infections in liver transplant recipients. Clin Infect Dis 1995, 21:1077–1089.

    PubMed  CAS  Google Scholar 

  14. Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994: 220:751–758.

    PubMed  Article  CAS  Google Scholar 

  15. Zaoutis TE, Argon T, Chu J, et al.: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41:1232–1239.

    PubMed  Article  Google Scholar 

  16. Bougnoux ME, Kac G, Aegerter P, et al.: CandiRea Study Group: Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008, 34:292–299.

    PubMed  Article  Google Scholar 

  17. Olaechea PM, Palomar M, Léon-Gil C, et al.: Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004, 23:323–330.

    PubMed  Article  CAS  Google Scholar 

  18. Bassetti M, Righi E, Costa A, et al.: Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006, 6:21.

    PubMed  Article  Google Scholar 

  19. Pappas PG, Rex JH, Sobel JD, et al.: Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161–189.

    PubMed  Article  Google Scholar 

  20. Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001, 32:1191–1200.

    PubMed  Article  CAS  Google Scholar 

  21. Savino JA, Agarwal N, Wry P, et al.: Routine prophylactic antifungal agents (clotrimazole, ketoconazole and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994, 36:20–25.

    PubMed  CAS  Google Scholar 

  22. Ables A, Blumer N, Valginis G, et al.: Fluconazole prophylaxis of severe Candida infection in trauma and postsurgical patients: a prospective, double-blind, randomized, placebo-controlled trial. Infect Dis Clin Pract 2000, 9:169–175.

    Article  Google Scholar 

  23. Charles PE, Dalle F, Gube H, et al.: Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 2005, 31:393–400.

    PubMed  Article  Google Scholar 

  24. Petri MG, Konig J, Moecke HP, et al.: Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 1997, 23:317–325.

    PubMed  Article  CAS  Google Scholar 

  25. Pelz RK, Lipsett PA, Swoboda M, et al.: The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect (Larchmt) 2000, 1:273–281.

    Article  CAS  Google Scholar 

  26. Stephan F, Bah MS, Desterke C, et al.: Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit as studied using microsatellite markers. Clin Infect Dis 2002, 35:1477–1483.

    PubMed  Article  Google Scholar 

  27. Cruciani M, de Lalla F, Mengoli C: Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005, 31:1479–1487.

    PubMed  Article  Google Scholar 

  28. Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2006, 25:CD0049.

    Google Scholar 

  29. Shorr AF, Chung K, Jackson WL, et al.: Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005, 33:1928–1935.

    PubMed  Article  CAS  Google Scholar 

  30. Cruciani M, Mengoli C, Malena M, et al.: Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl 2006, 12:850–858.

    PubMed  Article  Google Scholar 

  31. Playford EG, Webster AC, Sorrell TC, Craig JC: Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 2006, 25:549–561.

    PubMed  Article  CAS  Google Scholar 

  32. Singh N: Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design. Clin Infect Dis 2004, 39:S200–S206.

    PubMed  Article  Google Scholar 

  33. Piarroux R, Grenouillet F, Balvay P, et al.: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32:2443–2449.

    PubMed  Article  Google Scholar 

  34. Takesue Y, Kakehashi M, Ohge J, et al.: Combined assessment of beta-J-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 2004, 28:625–630.

    PubMed  Article  Google Scholar 

  35. Ostrosky-Zeichner L, Alexander B, Kett DH, et al.: Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654–659.

    PubMed  Article  CAS  Google Scholar 

  36. McMullan R, Metwally L, Coyle PV, et al.: A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in non-neutropenic, critically ill adults. Clin Infect Dis 2008, 46:890–896.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Toronto General Hospital, University Health Network, NCSB 11-1212, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada

    Coleman Rotstein

Authors
  1. Coleman Rotstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Coleman Rotstein.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rotstein, C. Invasive candidiasis in the ICU: Prophylaxis versus preemptive treatment. Curr Infect Dis Rep 10, 454 (2008). https://doi.org/10.1007/s11908-008-0074-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-008-0074-z

Keywords

  • Candidiasis
  • Intensive Care Unit Patient
  • Antifungal Therapy
  • Posaconazole
  • Invasive Candidiasis